Iterum Therapeutics plc (ITRMF) Change in Acquisitions & Divestments (2017 - 2024)

Iterum Therapeutics' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $1.1 million for Q4 2024.

• In Q4 2024, Change in Acquisitions & Divestments fell 94.12% year-over-year to $1.1 million; the TTM figure through Sep 2025 stood at $1.1 million (down 97.72% YoY), while the FY2024 annual figure was $30.6 million, down 52.58% from the prior year.
• Change in Acquisitions & Divestments for Q4 2024 stood at $1.1 million, down from $5.7 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $27.3 million in Q2 2023, with the low at $1.1 million in Q4 2024.
• The 4-year median for Change in Acquisitions & Divestments is $10.1 million (2024), against an average of $12.1 million.
• The sharpest annual moves came in 2022 and 2024: Change in Acquisitions & Divestments jumped 464.0% in 2022, then plunged 94.12% in 2024.
• Iterum Therapeutics' Change in Acquisitions & Divestments stood at $2.5 million in 2021, then surged by 464.0% to $14.1 million in 2022, then jumped by 32.62% to $18.7 million in 2023, then slumped by 94.12% to $1.1 million in 2024.
• Business Quant data shows ITRMF's Change in Acquisitions & Divestments at $1.1 million in Q4 2024, $5.7 million in Q3 2024, and $10.1 million in Q2 2024.